Connect with us
  • Elysium

Parkinson's news

New Parkinson’s drug shows positive results in preclinical studies

Published

on

New Parkinson’s drug shows positive results in preclinical studies

IRLAB’s drug mesdopetam has displayed antipsychotic properties in an advanced model of Parkinson’ s disease psychosis (PD-P).

Discover:

- IRLAB's preclinical results from mesdopetam in an advanced preclinical model of PD-P
- Mesdopetam's potential as a novel therapeutic in PD-P
- The role of the dopamine D3 receptor in PD-P

Read this and more exclusive content every day as an NR Times online subscriber. Just £2.99 a month, cancel anytime.


Login Join Now

HIWIN

Trending